Baxter Reveals Results From Combined IMPENDIA/EDEN Trials

Baxter International said results from two large, international multicenter trials demonstrated that a low glucose peritoneal dialysis, or PD, regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids.
RTT News